Stay updated on T-DXd in HER2 Expressing Tumors Clinical Trial
Sign up to get notified when there's something new on the T-DXd in HER2 Expressing Tumors Clinical Trial page.

Latest updates to the T-DXd in HER2 Expressing Tumors Clinical Trial page
- Check4 days agoChange DetectedThe page now renders a 403 Forbidden error, replacing the study-record content with a generic error page and navigation/footer, indicating restricted access to the study record.SummaryDifference19%

- Check11 days agoChange DetectedRevision: v3.7.0 appears instead of Revision: v3.6.6, signaling a recent site update rather than a change to the study details or content.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThis update shows the site/versioning revision to v3.6.6. It indicates a maintenance release that does not modify the study information presented on the page.SummaryDifference0.0%

- Check32 days agoChange DetectedThe study identifiers section now includes a 2023 U.S. NIH Grant/Contract entry, reflecting NIH funding attribution for this trial.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a new build/version of the site. This typically reflects maintenance or small fixes and does not change the study details shown on the page.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page now displays Revision: v3.6.4, updating the site version tag from v3.6.3 to v3.6.4, which reflects a backend/template update rather than changes to trial details.SummaryDifference0.0%

Stay in the know with updates to T-DXd in HER2 Expressing Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-DXd in HER2 Expressing Tumors Clinical Trial page.